Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Vinmec Times City International Hospital is the first organization in Vietnam to receive certification from both the College of American Pathologists (CAP) Laboratory Accreditation Program (LAP) and Joint Commission International, marking a significant turning point in Vietnam's approach to health care quality control. This article shares our journey toward CAP accreditation, offering insights from a laboratory in a developing nation. The data sources include documentation of our laboratory's experiences during 2 years (2020-2022), illustrating the collaborative work and achievements in preparing for the first inspection of the CAP LAP, alongside prior discussions and commitments (2018-2020) to develop our plan. By working as a cohesive team of pathologists and staff, with a well-thought-out plan and strong support from the hospital's executive leadership and administrative team, Vinmec Times City International Hospital in Hanoi was able to take the initial steps toward achieving and maintaining an international standard in laboratory quality management.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5858/arpa.2024-0266-SA | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Indolicidin derivatives as potent dual-action antifungal and antibacterial agents for the treatment of skin infections: A comprehensive study from in vitro to in vivo evaluation.
PLoS One
September 2025
Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam.
As listed by the WHO, the emergence of antibiotic-resistant pathogens, particularly Staphylococcus aureus and Pseudomonas aeruginosa, highlights the urgent need for novel antimicrobial agents. In parallel, fungal infections, especially those caused by Candida albicans, have also become increasingly prevalent and clinically challenging, further emphasizing the necessity for broad-spectrum therapeutic strategies. In particular, skin and soft tissue infections (SSTIs) caused by these bacteria and fungal are common in humans and can lead to severe complications if left untreated.
View Article and Find Full Text PDFOutcomes of Allogenic Umbilical Cord Mesenchymal Stem Cell infusion for Liver Cirrhosis due to Biliary Atresia after Kasai Operation.
J Pediatr Surg
September 2025
Children's Hospital 2, Ho Chi Minh City, Vietnam. Electronic address:
Background And Aim: Although Kasai surgery has saved many patients with biliary atresia, the long-term survival rate remains low. Recently, cell therapy has been explored as a potential strategy to improve post-surgical survival. This study aims to evaluate the safety and outcomes of allogeneic umbilical cord mesenchymal stem cell (UC-MSC) infusion in management of liver cirrhosis due to Biliary Atresia after Kasai Operation.
View Article and Find Full Text PDFThe first case report of chylous ascites in a twin pregnancy following fertilization: a case report of chylous ascites in twin pregnancy.
Ann Med Surg (Lond)
September 2025
Vinmec Times City International Hospital, Hanoi, Vietnam.
Introduction And Importance: Chylous ascites is an exceptionally rare condition during pregnancy, typically presenting with nonspecific symptoms. To date, only a limited number of cases have been reported in the literature, and the majority of which occurred in singleton pregnancies.
Case Presentation: We report the case of a 25-year-old woman with a twin pregnancy who was admitted at 32 weeks of gestation with acute abdominal pain and nausea.
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension.
J Allergy Clin Immunol Pract
August 2025
Institute of Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universitätsmedizin Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany. Electronic a
Background: Poor compliance with hereditary angioedema guidelines for on-demand treatment is common due to challenges with parenteral administration. Sebetralstat, an oral plasma kallikrein inhibitor, demonstrated faster times to beginning of symptom relief, reduction in attack severity, and complete resolution than placebo in the phase 3 KONFIDENT trial (NCT05259917).
Objective: This analysis evaluated long-term safety and effectiveness of sebetralstat in KONFIDENT-S (NCT05505916), an ongoing, 2-year, open-label extension study.
Case Report: A Bilateral Synchronous Primary Non-Small Cell Lung Cancer Patient With Two Different EGFR Mutations.
Cancer Rep (Hoboken)
August 2025
Vinmec-VinUni Institute of Immunology, College of Health Sciences, VinUniversity, Hanoi, Vietnam.
Background: Non-small cell lung cancer (NSCLC) represents the majority of lung cancer cases, with epidermal growth factor receptor (EGFR) mutations playing a crucial role in disease prognosis and treatment. Around half of Asian patients with NSCLC, particularly non-smoking women, have EGFR mutations. These patients with NSCLC typically exhibit a single EGFR mutation in exon 18, 19, 20, or 21.
View Article and Find Full Text PDF